$54.29
3.59% yesterday
NYSE, Dec 15, 10:10 pm CET
Why the stock moved Why the stock moved Beta
ISIN
US1101221083
Symbol
BMY

Bristol-Myers Squibb Stock price

$54.29
+7.48 15.98% 1M
+5.63 11.57% 6M
-2.27 4.01% YTD
-1.58 2.83% 1Y
-20.71 27.61% 3Y
-8.28 13.23% 5Y
-15.93 22.69% 10Y
+32.43 148.35% 20Y
NYSE, Closing price Mon, Dec 15 2025
+1.88 3.59%

New AI Insights on Bristol-Myers Squibb Insights AI Insights on Bristol-Myers Squibb

How does the company make money?
Who are the company’s main competitors?
What are the key opportunities and risks?
How is the company managed?

Key metrics

Basic
Market capitalization
$110.5b
Enterprise Value
$143.0b
Net debt
$32.5b
Cash
$16.5b
Shares outstanding
2.0b
Valuation (TTM | estimate)
P/E
18.3 | 8.2
P/S
2.3 | 2.3
EV/Sales
3.0 | 3.0
EV/FCF
9.3
P/B
6.0
Dividends
DPS
$2.49
Yield 1Y | 5Y
4.6% | 3.8%
Growth 1Y | 5Y
2.9% | 6.2%
Payout 1Y | 3Y
-54.9% | 288.3%
Increased
19 Years
Financials (TTM | estimate)
Revenue
$48.0b | $48.4b
EBITDA
$20.3b | $17.4b
EBIT
$16.1b | $15.9b
Net Income
$6.0b | $13.5b
Free Cash Flow
$15.3b
Growth (TTM | estimate)
Revenue
1.3% | 0.2%
EBITDA
-1.5% | -14.6%
EBIT
44.7% | 38.1%
Net Income
183.2% | 250.3%
Free Cash Flow
10.9%
Margin (TTM | estimate)
Gross
73.2%
EBITDA
42.2% | 36.0%
EBIT
33.5%
Net
12.6% | 27.8%
Free Cash Flow
31.9%
Financial Health
Equity Ratio
17.6%
Return on Equity
-54.8%
ROCE
23.4%
ROIC
16.9%
Debt/Equity
2.6
More
EPS
$3.0
FCF per Share
$7.5
Short interest
1.7%
Employees
34k
Rev per Employee
$1.4m
Show more

Is Bristol-Myers Squibb a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,086 stocks worldwide.

Bristol-Myers Squibb Stock Analysis

Unlock Scores for Free

Analyst Opinions

34 Analysts have issued a Bristol-Myers Squibb forecast:

11x Buy
32%
21x Hold
62%
2x Sell
6%

Analyst Opinions

34 Analysts have issued a Bristol-Myers Squibb forecast:

Buy
32%
Hold
62%
Sell
6%

Financial data from Bristol-Myers Squibb

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '25
+/-
%
48,034 48,034
1% 1%
100%
- Direct Costs 12,898 12,898
13% 13%
27%
35,136 35,136
2% 2%
73%
- Selling and Administrative Expenses 7,167 7,167
10% 10%
15%
- Research and Development Expense 9,719 9,719
3% 3%
20%
20,280 20,280
1% 1%
42%
- Depreciation and Amortization 4,184 4,184
56% 56%
9%
EBIT (Operating Income) EBIT 16,096 16,096
45% 45%
34%
Net Profit 6,039 6,039
183% 183%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Bristol-Myers Squibb directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Bristol-Myers Squibb Stock News

Positive
The Motley Fool
one day ago
These two pharmaceutical giants have faced -- or will soon face -- patent cliffs. Both are innovative drugmakers, which should allow them to overcome this issue.
Positive
The Motley Fool
3 days ago
Chevron is an integrated energy company with an impressive yield and an impressive dividend history. Bristol Myers has a high yield, but the drugmaker is out of favor.
Positive
Seeking Alpha
3 days ago
This article presents a diversified, fund-based portfolio targeting market-matching growth and a 6%+ income yield, with lower tech exposure than the S&P 500. The model portfolio, comprising 5 ETFs and 6 CEFs, emphasizes asset class diversification—spanning blue-chip dividends, tech, real estate, gold, materials, energy, and utilities. The portfolio presented uses ahands-off approach, and it is ...
More Bristol-Myers Squibb News

Company Profile

Bristol-Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. The firm offers chemically-synthesized drugs or small molecules and products produced from biological processes called biologics. The company was founded in August 1933 and is headquartered in New York, NY.

Head office United States
CEO Christopher Boerner
Employees 34,100
Founded 1933
Website www.bms.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today